Melanoma vaccine

Hundred percent development argentinoUna melanoma vaccine ready for final test Will be tested in 108 patients with skin cancer, would be available in 3 or 4 years.

Argentine researchers have developed a vaccine to treat melanoma, the most common form of cancer in people aged between 15 and 44 years will begin in the coming months with phase studies in patients prior to approval by authorities local regulatory. If you pass this last test, called Vaccimel vaccine could be available in 3 to 4 years. "After three years of receiving the vaccine, 70% of patients in advanced stages of melanoma who participated in clinical studies so far remained free of disease," said Dr. Marcela Barrio, CONICET researcher involved in the development of Vaccimel, during a press conference held in Expo-Medical.

FAQ Bru therapy

What is therapy?
The therapy is cause neutrophilia (neutrophil count elevation) in the vicinity of the patient's tumors ...


Neutrophils are immune cells that, unlike other body cells, supporting the acidic environment generated by the tumor environment. According to the work of A. Bru, these cells are capable of exerting pressure on the tumor. Tumor cells pressurized first enter a quiescent state, which do not divide, and then die by necrosis. To cause neutrophilia is injected the patient Neupogen ®.

Out of context

Sometimes silence is not one or two pieces of evidence or not to read in Polish ... .. attitude just a little reluctant ... ...

Olympics a little bit of contempt which is considered an upstart and a little bit of pride and corporatism to admit that unfortunately the much-worn "scientific method" has not been responsible or the 10% of the great discoveries of mankind and also Unfortunately (for patients) 1000 Oncologists continue to fail than 100,000 times a year without the 100 failures per capita serve for a high pedestal of wounded pride and put the hard work to provide all necessary support to clarify the real limits and the real possibilities of something that sometimes starts with one or two pieces of evidence that seem to contradict the paradigm "official" and end in late Nobel Prize ....